Biosimilars Market Research Reports & Industry Analysis
The worldwide prescription generic drug market has stood the test of time and has endured numerous growing pains. However, it has evolved into a formidable and important participant in the complex world of health care. Generic drugs continue to represent one of the greatest values in healthcare and are of great importance in the area of biopharmaceuticals as well because these products are among the most expensive treatments currently on the market.
Generic drug manufacturers are poised for strong growth in the future because the patent protection for a host of major biopharmaceuticals will expire and new legislative reforms in the generic drug approval process may facilitate bringing products to market. While there are many issues to address, the outlook for the promotion of biosimilars is favorable in the next five years.
Biosimilars Industry Research & Market Reports
-
Biosimilars Market Size Outlook in 2023 and Beyond: Market Trends, Insights, Growth Opportunities, Market Share and Forecasts by Types, Applications, Countries and Companies to 2030
... in the sector in 2023 and beyond. The Biosimilars market report analyzes the Biosimilars market growth opportunities, trends, insights, and market size outlook across types, applications, and countries. Biosimilars market dynamics including trends, drivers, growth ... Read More
-
2023 Global Biosimilars Market Industry (2029 Outlook)
... three-year historical trend (2017-2020), a three-year forecast estimate trends (2021-2023), and a five-year outlook projection (2024-2029) for 46 countries. Market and product shipments include the total value of all products produced and shipped by all ... Read More
-
Global PEGylated Proteins Market Size study & Forecast, by Protein Type (Colony-stimulating factor, Interferons, Erythropoietin, Recombinant factor VII, Others), by Product & Services (Consumables, Services), by Application (Cancer, Autoimmune diseases, Hepatitis, Multiple sclerosis, Hemophilia, Gastrointestinal disorders, Others), by End-User (Pharmaceutical & biotechnology companies, Contract research organizations, Academic & research institutes), and Regional Analysis, 2022-2029
... disorders, Others), by End-User (Pharmaceutical & biotechnology companies, Contract research organizations, Academic & research institutes), and Regional Analysis, 2022-2029 Global PEGylated Proteins Market is valued at approximately USD 1.14 billion in 2021 and is anticipated ... Read More
-
Global Bioprocess Analyzers Market Size study & Forecast, by Product (Instrument and Consumables), Application (Antibiotics, Recombinant Proteins, Biosimilars, Other Applications), Type (Substrate Analysis, Metabolite Analysis, and Concentration Detection), and Regional Analysis, 2022-2029
... Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 10.1% over the forecast period 2022-2029. Bioprocess Analyzers help in the quick ... Read More
-
Biosimilars Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... the biosimilars market may be significant, and it has imposed a great challenge on the pharmaceutical companies focused on biosimilar development. The reduction in the approval by regulatory bodies of non-COVID therapeutics during the current ... Read More
-
Biosimilar Contract Manufacturing Market – Global Outlook & Forecast 2022-2027
... cannot afford life-saving medicines, putting their lives at risk. Producing potentially life-saving drugs that are more accessible and affordable can help today's patients live better lives for a prolonged period and minimize health inequality. Biologic ... Read More
-
Global Biosimilar Insulin Market Growth 2023-2029
... designed to be highly similar to the original, or reference, insulin product described in a patent. They are analogous to generic versions of small-molecule drugs and are developed by companies other than the reference product's ... Read More
-
Global Biosimilar Market Growth (Status and Outlook) 2023-2029
... manufactured by a different company. Biosimilar are officially approved versions of original "innovator" products and can manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval. ... Read More
-
Global Interferon Alpha-2a Biosimilar Market Growth 2023-2029
... DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences. LPI (LP Information)' newest research report, the “Interferon ... Read More
-
Global Biosimilar Drug Market Growth 2023-2029
... from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine. A biosimilar in this report is a ... Read More
-
Global Biologics and Biosimilars Market Growth 2023-2029
... derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. A biosimilar in this report is ... Read More
-
2023 Global Forecast for Cardiac Safety Services Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... countries. The global market is expected to increase from USD xx billion in 2024 to USD xx billion by 2029, at a CAGR of xx% from 2024 to 2029. Estimates on equipment or material sales ... Read More
-
Global Biologics CDMO Market 2022-2028
... edition of the Global Biologics CDMO Market Report. The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global biologics CDMO market. It traces the market’s historic and forecast ... Read More
-
Access Control as a Service Market (ACaaS) by Access Control Models(RBAC, DAC), Service Type (Hosted, Managed, Hybrid), Cloud Deployment (Public Cloud, Private Cloud), Vertical (Commercial, Residential, Government, Retail) Region - Global Forecast to 2027
... global access control as a service market was valued at USD 0.9 billion in 2021 and is projected to reach USD 2.2 billion by 2027, registering a CAGR of 16.4% during the forecast period. The ... Read More
-
Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2022
... they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. ... Read More
-
Adalimumab, Infliximab And Etanercept Biosimilars Global Market Opportunities And Strategies To 2031
... management with the critical information they need to assess the global adalimumab, infliximab and etanercept biosimilars market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Biosimilars Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... the biosimilars market may be significant, and it has imposed a great challenge on the pharmaceutical companies focused on biosimilar development. The reduction in the approval by regulatory bodies of non-COVID therapeutics during the current ... Read More
-
SOUTH KOREA DIABETES DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... 2022-2027. The market is estimated to reach a value of more than USD 1 billion by 2027. The COVID-19 pandemic positively impacted the Diabetes Drugs market growth in South Korea. Patients with diabetes, infected with ... Read More
-
CHINA DIABETES CARE DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... WHO, 20% of persons with diabetes and diabetes-related disorders died in China in January 2020 COVID-19 fatalities. Diabetes affects about one out of every ten COVID-19 patients in China. Diabetes is linked to an increased ... Read More
-
Biological Safety Cabinet Market by Type (Class I, Class II (Type A, Type B), Class III), End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories, Academic Research Institutes), and Region - Global Forecast to 2027
... 2027 The global biological safety cabinet market is projected to reach USD0.4billion by 2027 from USD0.2billion in 2022, at a CAGR of 8.2% during the forecast period. Market growth is driven by factors such as ... Read More
-
Global Human Insulin Drugs and Delivery Devices Market Size study, by Drug Type (Basal or Long-acting Insulins, Bolus or Fast-acting Insulins, Traditional Human Insulins, Combination Insulins, and Biosimilar Insulins), by Device Type (Insulin Pens, Insulin Pumps, Insulin Syringes, and Jet Injectors) and Regional Forecasts 2022-2028
... Pumps, Insulin Syringes, and Jet Injectors) and Regional Forecasts 2022-2028 Global Human Insulin Drugs and Delivery Devices Market is valued at approximately USD 40.3 billion in 2021 and is anticipated to grow with a healthy ... Read More
-
North America Biosimilars Market Size, Share & Industry Trends Analysis Report By Application (Oncology Diseases, Blood Disorders, Chronic & Autoimmune Diseases and Others), By Type, By Country and Growth Forecast, 2022 - 2028
... America Biosimilars Market would witness market growth of 23.6% CAGR during the forecast period (2022-2028). Biosimilars are rigorously and thoroughly examined by the FDA before approval, and they are just as secure and efficient as ... Read More
-
Europe Biosimilars Market Size, Share & Industry Trends Analysis Report By Application (Oncology Diseases, Blood Disorders, Chronic & Autoimmune Diseases and Others), By Type, By Country and Growth Forecast, 2022 - 2028
... Market would witness market growth of 23.6% CAGR during the forecast period (2022-2028). The prevalence of autoimmune conditions like rheumatoid arthritis & ankylosing spondylitis is rising, fueling the growth of the biosimilars market. For the ... Read More
-
Global Biosimilars Market Size, Share & Industry Trends Analysis Report By Application (Oncology Diseases, Blood Disorders, Chronic & Autoimmune Diseases and Others), By Type, By Regional Outlook and Forecast, 2022 - 2028
... Market size is expected to reach $59 billion by 2028, rising at a market growth of 24.4% CAGR during the forecast period. Biosimilar medicines are biotherapeutic products that are identical to an approved reference product ... Read More
-
Global Biosimilars Market (2022 Edition) – Analysis By Product Type, Application, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2023-2028)
... Billion in the year 2021 with the Europe region leading the regional market share. One of the main factors driving this market is the expiration of patents of major pharmaceutical drugs and thus the opportunity ... Read More
Research Assistance
